Search research articles
Contact Us
Filters
Showing results (221-230 of 272) with videos related to
Page
of 28
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2000
Phase I study of topotecan administered as a 21-day continous infusion in children with recurrent solid tumors: a report from the Children's Cancer Group
H Frangoul, M M Ames, R B Mosher, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 5, 2008
Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition
Paul V Fish, Christopher Deur, Xinmin Gan, et al.
Genome Announcements
|
November 7, 2015
Genome Sequence of Porphyromonas gingivalis Strain AJW4
Gary Xie, Ryan P Chastain-Gross, Myriam Bélanger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2003
Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children's Cancer Group Study 2951
Robert J Wells, Mary T Adams, Todd A Alonzo, et al.
Genome Announcements
|
September 26, 2015
Genome Sequence of Porphyromonas gingivalis Strain A7436
Ryan P Chastain-Gross, Gary Xie, Myriam Bélanger, et al.
The American Journal of Cardiology
|
January 1, 1990
Relation of silent myocardial ischemia after coronary artery bypass grafting to angiographic completeness of revascularization and long-term prognosis
H L Kennedy, S M Seiler, M K Sprague, et al.
Haematologica
|
March 2, 2016
Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation
Inge M van der Sluis, Lynda M Vrooman, Rob Pieters, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 4, 2009
N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration
Florian Wakenhut, Gill A Allan, Paul V Fish, et al.
Blood
|
October 7, 2017
Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemia
Alan S Wayne, Nirali N Shah, Deepa Bhojwani, et al.
Chemical Biology & Drug Design
|
July 5, 2012
Identification of type-II inhibitors using kinase structures
Frank Lovering, Joseph McDonald, Gavin A Whitlock, et al.
Page
of 28
Search research articles
Search
Showing results (221-230 of 272) with videos related to
Sort By:
Page
of 28
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2000
Phase I study of topotecan administered as a 21-day continous infusion in children with recurrent solid tumors: a report from the Children's Cancer Group
H Frangoul, M M Ames, R B Mosher, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 5, 2008
Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition
Paul V Fish, Christopher Deur, Xinmin Gan, et al.
Genome Announcements
|
November 7, 2015
Genome Sequence of Porphyromonas gingivalis Strain AJW4
Gary Xie, Ryan P Chastain-Gross, Myriam Bélanger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2003
Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children's Cancer Group Study 2951
Robert J Wells, Mary T Adams, Todd A Alonzo, et al.
Genome Announcements
|
September 26, 2015
Genome Sequence of Porphyromonas gingivalis Strain A7436
Ryan P Chastain-Gross, Gary Xie, Myriam Bélanger, et al.
The American Journal of Cardiology
|
January 1, 1990
Relation of silent myocardial ischemia after coronary artery bypass grafting to angiographic completeness of revascularization and long-term prognosis
H L Kennedy, S M Seiler, M K Sprague, et al.
Haematologica
|
March 2, 2016
Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation
Inge M van der Sluis, Lynda M Vrooman, Rob Pieters, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 4, 2009
N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration
Florian Wakenhut, Gill A Allan, Paul V Fish, et al.
Blood
|
October 7, 2017
Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemia
Alan S Wayne, Nirali N Shah, Deepa Bhojwani, et al.
Chemical Biology & Drug Design
|
July 5, 2012
Identification of type-II inhibitors using kinase structures
Frank Lovering, Joseph McDonald, Gavin A Whitlock, et al.
Page
of 28